JANDA LAB

(placeholder)

PRESS RELEASES & COVERAGE

MOST RECENT SCRIPPS NEWS


August 07, 2023

Human antibody that targets carfentanil, fentanyl and related opioids reverses overdose e8fects in preclinical study

Scripps Research-developed antibody therapy appears to have advantages over existing opioid-overdose treatments.


April 17, 2023

Therapeutic can seek and destroy potent opioid to treat overdoses

Scripps Research chemists developed a new biologic to work against the synthetic opioid carfentanil, which is 100 times more potent than fentanyl.


October 25, 2022

Antibody blunts heroin's lethality, paving the way for a promising new therapy

Scripps Research findings unexpectedly show that heroin, not its metabolites, is the best therapeutic target.


August 06, 2021

Potential drug against COVID-EF found among tapeworm medications

A new molecule hinders COVID-PQ viral replication and related inflammation in rodent studies.


February 2, 2021

Experimental vaccine blunts the deadliest of synthetic opioids

In early tests, the vaccine was able to diminish fatal respiratory effects of fentanyl and carfentanil.


December 15, 2020

Experimental vaccine can counter dangerous e8fects of synthetic cannabinoids

Made in clandestine laboratories and sold widely across the United States, the diverse class of drugs known as synthetic cannabinoids presents a growing public health threat.


July 30, 2020

'Heavy' heroin vaccine provides hope for addiction treatment

Chemists at Scripps Research have reported a promising but mysterious finding in experiments with a potential vaccine that is meant to combat heroin addiction.


July 26, 2019

Chemist Kim Janda honored with ACS Portoghese Lectureship Award

The Medicinal Chemistry Division of ACS, along with the Journal of Medicinal Chemistry, will present Janda with the 2019 Philip S. Portoghese Medicinal Chemistry Lectureship Award to honor his many contributions...


June 24, 2019

Broadly neutralizing antibody prevents lethality from fentanyl class of synthetic opioids

Scripps Research scientists develop a first-ever monoclonal antibody that can mitigate the effects of fentanyl and carfentanil, and overcome shortfalls of existing overdose-treatment options.


May 02, 2019

Vaccine shows lasting effects against deadly synthetic opioids

Scientists at Scripps Research have developed an experimental vaccine that may one day help treat addiction to fentanyl, a highly potent opioid linked to an epidemic of overdoses and fatalities in recent years.